"Fundación CIDEA es una entidad civil sin fines de lucro con el objeto de dedicarse a la investigación, docencia, asistencia, diagnóstico, tratamiento y difusión en el área de las enfermedades alérgicas, asma y otras enfermedades respiratorias, y su relación con la medicina en general."

During the past decade, Fundacion CIDEA conducted 3 clinical trials. In the 10-year time frame, 3 clinical trials started and 2 clinical trials were completed, i.e. on average, 66.7% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 2 clinical trials were completed. i.e. 200% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Fundacion CIDEA" #1 collaborator was "Incyte Corporation" with 3 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 1 trials.

According to Clinical.Site data, the most researched conditions in "Fundacion CIDEA" are "Atopic Dermatitis" (3 trials). Many other conditions were trialed in "Fundacion CIDEA" in a lesser frequency.

Most popular intervention types in "Fundacion CIDEA" are "Drug" (3 trials). Other intervention types were less common.

The name of intervention was led by "Baricitinib" (3 trials), "Placebo" (3 trials) and "Topical corticosteroid" (2 trials). Other intervention names were less common.

The vast majority of trials in "Fundacion CIDEA" are 3 trials for "All" genders.

Currently, there are NaN active trials in "Fundacion CIDEA". undefined are not yet recruiting, 1 are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 1 completed trials in Fundacion CIDEA, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Fundacion CIDEA, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 3 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".